Home / Journals Cancer Research Journal / Tumor-Association Inflammation
Tumor-Association Inflammation
Submission Deadline: Jul. 30, 2015
Lead Guest Editor
Nina Gridina
Laboratory of Experimental Neurosurgery, A. P. Romodanov Institute of Neurosurgery of National Academy of Sciences of Ukraine, Kiev, Ukraine
Guest Editor
Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=158). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.
Malignant tumor problems is very difficult, because is unknown the nature of disease. Pathogenesis of tumors has two parts: tumor-association inflammation (TAI) and solid tumor, but what is it “solid tumor” –is not clear. TAI has peculiarities and differs from inflammation of non- tumor genesis. Some characteristics of malignant tumors belong to TAI. For example: resistance to many kind of therapy. So, monocytes can pump out drugs, as cancer cells, because it must works in an inflammation locus; many toxic substances have similar nature in tumor and in TAI and so on. TAI has also malignant characteristic features as tumor. The inhibition of TAI lead to inhibition of tumor growth. The major conception of tumor growth is the cells mutations. The investigations of TAI can lead to understanding the nature of solid tumor. The investigation of lymphocytes chromosomes aberration reveals the dependence of number of chromosomal aberration from transmembrane potential. Such investigations can lead to new comprehensive of tumor pathogenesis.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186